Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT01718743. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Patient and Care Partner Experiences Living With Multiple Myeloma (PaCE-MM)
ClinicalTrials.gov study NCT05276622. IPD Sharing: NO. Countries: 1. Publications: 0.
Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma
ClinicalTrials.gov study NCT00918333. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bendamustine Hydrochloride, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT02224729. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05730036. IPD Sharing: YES. Countries: 18. Publications: 0.
Aflibercept for Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT00437034. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT01559935. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
ClinicalTrials.gov study NCT07393282. IPD Sharing: YES. Countries: 0. Publications: 0.
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
ClinicalTrials.gov study NCT07105059. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01160380. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma
ClinicalTrials.gov study NCT00099047. IPD Sharing: Not stated. Countries: 1. Publications: 0.
UARK 2009-09 Myeloma Cure Project: Prospective Trial of Indefinite Revlimid Maintenance Versus Observation for Currently Event-Free Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01621672. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT02100657. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Home Based Daratumumab Administration for Patients With Multiple Myeloma
ClinicalTrials.gov study NCT05511428. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
ClinicalTrials.gov study NCT00721734. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multiple Myeloma (MM) Quality of Life (QOL) Study
ClinicalTrials.gov study NCT04388735. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of BTK Inhibitor, Ibrutinib in Combination With Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01962792. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy
ClinicalTrials.gov study NCT00691704. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM)
ClinicalTrials.gov study NCT01303965. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carfilzomib in Treating Patients With Multiple Myeloma in First Relapse or Refractory to First-Line Therapy
ClinicalTrials.gov study NCT02020941. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.